Suppr超能文献

芬兰、波兰和瑞典的乳糖酶持久性与卵巢癌风险

Lactase persistence and ovarian carcinoma risk in Finland, Poland and Sweden.

作者信息

Kuokkanen Mikko, Butzow Ralf, Rasinperä Heli, Medrek Krzysztof, Nilbert Mef, Malander Susanne, Lubinski Jan, Järvelä Irma

机构信息

National Public Health Institute, Department of Molecular Medicine, Helsinki, Finland.

出版信息

Int J Cancer. 2005 Oct 20;117(1):90-4. doi: 10.1002/ijc.21130.

Abstract

Ovarian carcinoma is the fourth most common cause of cancer death in women. The cause and pathogenesis of this disease has remained obscure. Galactose, the hydrolyzing product of the milk sugar lactose, has been hypothesized to be toxic to ovarian epithelial cells and consumption of dairy products and lactase persistence has been suggested to be a risk factor for ovarian carcinoma. In adults, downregulation of lactase depends on a variant C/T-13910 at the 5' end of the lactase gene. To explore whether lactase persistence is related to the risk of ovarian carcinoma we determined the C/T-13910 genotype in a cohort of 782 women with ovarian carcinoma. The C/T-13910 genotype was defined by solid phase minisequencing from 327 Finnish, 303 Polish, 152 Swedish patients and 938 Finnish, 296 Polish and 97 Swedish healthy individuals served as controls. Lactase persistence did not associate significantly with increased risk for ovarian carcinoma in the Finnish (odds ratio [OR]=0.77, 95% confidence interval [CI]=0.57-1.05, p=0.097), in the Polish (OR=0.95, 95% CI=0.68-1.33, p=0.75), or in the Swedish populations (OR=1.63, 95% CI=0.65-4.08, p=0.29). Our results do not support the hypothesis that lactase persistence increases the ovarian carcinoma risk. On the contrary, lactase persistence may decrease the ovarian carcinoma risk at least in the Finnish population.

摘要

卵巢癌是女性癌症死亡的第四大常见原因。这种疾病的病因和发病机制一直不明。乳糖的水解产物半乳糖被认为对卵巢上皮细胞有毒性,食用乳制品和乳糖酶持续性被认为是卵巢癌的一个危险因素。在成年人中,乳糖酶的下调取决于乳糖酶基因5'端的一个C/T-13910变体。为了探讨乳糖酶持续性是否与卵巢癌风险相关,我们在一组782名卵巢癌女性中测定了C/T-13910基因型。C/T-13910基因型通过固相微测序法确定,327名芬兰患者、303名波兰患者和152名瑞典患者作为研究对象,938名芬兰健康个体、296名波兰健康个体和97名瑞典健康个体作为对照。在芬兰人群中(优势比[OR]=0.77,95%置信区间[CI]=0.57-1.05,p=0.097)、波兰人群中(OR=0.95,95%CI=0.68-1.33,p=0.75)或瑞典人群中(OR=1.63,95%CI=0.65-4.08,p=0.29),乳糖酶持续性与卵巢癌风险增加均无显著相关性。我们的结果不支持乳糖酶持续性会增加卵巢癌风险这一假说。相反,至少在芬兰人群中,乳糖酶持续性可能会降低卵巢癌风险。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验